ClinicalTrials.gg
CompletedNCT07922278AROMA-MEDUpdated Nov 6, 2026

Aromatherapy Effects of Juniper and Thyme on Exam-Related Anxiety in Medical Students

An interventional study of Juniper Essential Oil Inhalation and Thyme Essential Oil Inhalation in Examination Anxiety, Test Anxiety and Situational Anxiety, sponsored by Gulbahar Boyuk Ozcan. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Gulbahar Boyuk Ozcan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jul 2024, registered Jul 2025).
Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 39 studies in Stress, Psychological with a site in Turkey — 9 open to participants now, 12 under way, none of them phase 3. Stress, Psychological · Turkey.

Enrollment
17th of 33
80 · median 80
Started
2024
with 6 others
No phase
33 of 39
7 open now
Registered
19th of 39
by date
Lead sponsor
2 of 39
Gulbahar Boyuk Ozcan

Among the 39 studies in Stress, Psychological with a site in Turkey, this one is the 17th largest by enrollment of the 33 interventional ones that give a count, is one of 7 that started in 2024, is one of 33 with no phase, and was the 19th registered.

Stress, Psychological

848 studies on the registry are indexed under Stress, Psychological; 139 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

9 of the 39 studies in Stress, Psychological with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 75 Stress, Psychological studies recruiting now, 34 (45%) set no upper age limit and 37 (49%) stop at 75 or younger; 14 take children under 18; 49 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Stress, Psychological with a site in Turkey, or all of them as a file.
02

Study summary

This clinical study investigates whether inhalation of juniper and thyme essential oils can reduce anxiety and related physiological symptoms in medical students during exam periods.

Eighty healthy university students, aged 18 to 25, will participate in this trial. Participants will inhale either juniper or thyme oil via aromatherapy before taking an academic examination.

The study will assess the effects on anxiety-related hormones (asprosin, cortisol, CREB) using saliva samples, and will measure physiological parameters such as heart rate, blood pressure, oxygen saturation, and body temperature before and after aroma inhalation.

This study aims to determine whether short-term exposure to essential oils can safely and effectively reduce exam-induced anxiety.

Read the detailed description

Exam anxiety is a common challenge among university students, particularly those in high-pressure fields like medicine. Anxiety negatively impacts cognitive performance and physiological balance, often raising stress hormone levels and affecting cardiovascular indicators.

This interventional study is designed to explore the therapeutic potential of aromatherapy using two essential oils-juniper (Juniperus communis) and thyme (Thymus vulgaris)-which are known for their anxiolytic and calming properties.

The study will be conducted at a medical faculty in Turkey during final examination periods. Participants will serve as their own controls, undergoing saliva collection and physiological monitoring before and after a brief aroma inhalation session.

Salivary samples will be analyzed for asprosin, cyclic AMP response element-binding protein (CREB), and cortisol concentrations using ELISA. Physiological measures such as systolic and diastolic blood pressure, heart rate, SpO₂, and body temperature will be monitored to assess autonomic nervous system response.

The findings of this study may provide new insights into non-pharmacological interventions for managing situational anxiety in academic and clinical settings. No serious risks are anticipated, as essential oils will be administered via inhalation in low concentrations for a limited duration under controlled conditions.

03

Conditions studied

  • Examination Anxiety
  • Test Anxiety
  • Situational Anxiety
  • Psychological Stress

Browse trials for

Keywords

  • Aromatherapy
  • Essential Oils
  • Juniper Oil
  • Thyme Oil
  • Exam Stress
  • Cortisol
  • Asprosin
  • CREB
  • Salivary Biomarkers
  • Medical Students
  • Physiological Response
  • Stress Reduction
  • Non-pharmacological Intervention
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Being willing to participate in the research, being a first-year medical student, being over 18 years old, being healthy

Exclusion criteria

Exclusion Criteria:

Having a communication barrier, incomplete form filling, menstruation in girls, allergies to thyme and juniper oil scents, any side effects during the application, having a cardiovascular disease, being pregnant, having any respiratory system disease (asthma, , etc.), having a condition that prevents smelling, using any medication that affects heart rate and blood pressure, or having a psychiatric disease.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    Arm 1: Juniper Aromatherapy Group

    Participants inhale juniper essential oil for 15 minutes prior to the exam. Physiological and hormonal measurements are taken immediately before and after the inhalation.

    Other: Juniper Essential Oil Inhalation

  • Experimental
    Arm 2: Thyme Aromatherapy Group

    Participants inhale thyme essential oil for 15 minutes prior to the exam. Physiological and hormonal measurements are taken immediately before and after the inhalation.

    Other: Thyme Essential Oil Inhalation

Interventions

  • OtherJuniper Essential Oil Inhalation

    Participants inhale 2 drops of juniper essential oil via an inhaler for 15 minutes prior to the exam session to evaluate effects on anxiety-related parameters.

  • OtherThyme Essential Oil Inhalation

    Participants inhale 2 drops of thyme essential oil via an inhaler for 15 minutes prior to the exam session to evaluate effects on anxiety-related parameters.

06

What researchers measure

Primary outcomes

  1. Change in Salivary Cortisol Levels

    Saliva samples will be collected immediately before and 15 minutes after aroma inhalation to measure cortisol levels using the ELISA method.

    Time frame: Baseline and 15 minutes post-inhalation

  2. Change in Salivary Asprosin Levels

    Saliva samples will be analyzed using the ELISA method to measure asprosin levels, serving as a physiological stress indicator.

    Time frame: Baseline and 15 minutes post-inhalation

  3. Change in Salivary CREB Levels

    Salivary CREB concentrations will be measured using the ELISA method to evaluate biochemical stress responses.

    Time frame: Baseline and 15 minutes post-inhalation

Secondary outcomes

  1. Change in Systolic and Diastolic Blood Pressure

    Blood pressure will be measured using an automated cuff to evaluate autonomic responses to aromatherapy.

    Time frame: Baseline and immediately post-inhalation

  2. Change in Heart Rate and Oxygen Saturation

    Heart rate and oxygen saturation (SpO₂) will be monitored using a pulse oximeter.

    Time frame: Baseline and immediately post-inhalation

07

Study locations

1 site
  • Ankara Medipol University
    Ankara, Ankara 06050, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) will not be shared due to ethical considerations and institutional restrictions.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2024 to primary completion in Jul 2024, 0 months.

Of 459 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 0 months is below that.

Counting every sponsor, half of 472 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2025
First posted
Nov 6, 2026
StartActual
Jul 7, 2024
Primary completionActual
Jul 20, 2024
CompletionActual
Oct 10, 2024
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07922278
Lead sponsor
Gulbahar Boyuk Ozcan
Responsible party
Gulbahar Boyuk Ozcan (Ankara Medipol University faculty of medicine, Ankara Medipol University) — Sponsor-investigator
First posted
Nov 6, 2026
Start date
Jul 7, 2024
Primary completion
Jul 20, 2024
Completion
Oct 10, 2024
Last update
Nov 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion